John Paul Ii Medical Research Institute
- Assets
- $327.7k
- Revenue
- $347.1k
- Investments
- $0.0
- Employees
- 7
- Location
- Coralville, IA
- Founding
- 01/2008
- Data as of
- 12/2023
- EIN
- 20-5239366
Organization Overview
John Paul Ii Medical Research Institute is located in Coralville, IA. The organization was established in 2008. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 12/2023, John Paul Ii Medical Research Institute employed 7 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. John Paul Ii Medical Research Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, John Paul Ii Medical Research Institute generated $347.1k in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 3.4% each year. All expenses for the organization totaled $499.7k during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
ADVOCATES FOR MEDICAL RESEARCH THAT RECOGNIZES THE DIGNITIY OF HUMAN LIFE FROM THE MOMENT OF CONCEPTION TO NATURAL DEATH AND ADDRESS UNMET MEDICAL NEEDS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
TO DEVELOP A COLLABORATIVE BASIC AND CLINICAL RESEARCH PROGRAM IN OUR FOUR CORE RESEARCH AREAS: CANCER, NEURODEGENERATIVE DISEASES, RARE DISEASES, AND ADULT STEM CELL THERAPIES. IN 2023, JP2MRI CONTINUED OUR RESEARCH EFFORTS INTO DEVELOPING AN IMMORTALIZED STEM CELL LINE TO REPLACE THE ABORTED FETAL CELL LINES BEING USED IN RESEARCH PHARMACEUTICAL APPLICATIONS. THE INSTITUTE ALSO CONTINUED ITS EFFORTS INTO DEVELOPING A SAFER AND MORE ROBUST CORONAVIRUS VACCINE UTILIZING A TRADITIONAL NON-MRNA BASED APPROACH THAT IS FREE OF ABORTED FETAL TISSUE DURING DEVELOPMENT AND TESTING.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Jay Kamath President | OfficerTrustee | 5 | $67,490 |
Dr Alan Moy Vice President | OfficerTrustee | 5 | $24,500 |
Dr James Becker Secretary | OfficerTrustee | 0.25 | $0 |
Jeanne Moy Director | Trustee | 0.25 | $0 |
Father Isaac Doucette Director | Trustee | 0.25 | $0 |
Dr Martin Bednar Director | Trustee | 0.25 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $346,818 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $346,818 |
| Total Program Service Revenue | $0 |
| Investment income | $270 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $347,088 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $93,892 |
| Compensation of current officers, directors, key employees. | $69,392 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $89,996 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $44,067 |
| Payroll taxes | $13,922 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $11,382 |
| Fees for services: Accounting | $5,988 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $370 |
| Advertising and promotion | $5,236 |
| Office expenses | $28,236 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $29,438 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $3,680 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $11,192 |
| Insurance | $812 |
| All other expenses | $4,128 |
| Total functional expenses | $499,711 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $272,929 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $35,476 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $19,288 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $327,693 |
| Accounts payable and accrued expenses | $9,000 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $3,125 |
| Secured mortgages and notes payable | $127,995 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $140,120 |
| Net assets without donor restrictions | $0 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $187,573 |
| Total liabilities and net assets/fund balances | $327,693 |